MTRC released a seminar on reimbursement system for IVD tests in China

08

May 2020

China is a very complex market with mostly regional market access activities. 

At the national level, only the scope of covered services is determined. The detailed scope of services and detailed benefit catalogs are established at the level of local administrative units (provinces and cities). 

In out-patient settings, a fee for service model is used for reimbursement of services and in-vitro diagnostic tests. 

We offer a seminar on critical elements of the reimbursement system for IVD tests in China, that can guide your decision-making about the introduction of novel technologies into this market. The seminar discusses key stakeholders, money flow, reimbursement in ambulatory settings for IVD tests, national and regional Benefit Catalogs and the role of HTA for market access of IVD tests.

Learn more and get a quote here

Related news

08

May 2020

In March-April, MTRC introduced a number of changes in the educational seminars on reimbursement systems in the Czech Republic and England and released additional modules about reimbursement of in-vitro diagnostic tests in Russia and Turkey.

Read more

09

Apr 2020

MTRC released the report on reimbursement of diagnostic testing for COVID-19 in six European countries (Belgium, France, Germany, Netherlands, Switzerland and Turkey). The report includes information about the availability of reimbursement, types of tests reimbursed, testing criteria. Download sample pages to assess the relevance of the report.

Read more

11

Mar 2020

Since autumn 2019, MTRC has started the release of the Market Access Magazine with an overview of key reimbursement news for the last quarter, along with analytical reviews on the topic of market access for medical technologies (reimbursement, funding, HTA, innovation payment schemes). Download free of charge from our website.

Read more

03

Mar 2020

On the 27th of February, MTRC Director Dr Oleg Borisenko presented at the roundtable on value-based health care and access to medical devices in Moscow, Russia.

Read more

24

Feb 2020

On the week of the 17th of February, MTRC published one post related to the involvement of industry in the reimbursement processes in Europe. Follow us on Instagram on @mtrc.market.access

Read more

19

Feb 2020

We have released the interview on the Market Access Insider channel on Youtube. The interview covered the role and activities of patient advocacy groups in Italy, typical issues facing by the patient organizations, role of patient organizations in development of the LEA catalog in Italy, access to stoma care across Italian regions, the importance of setting up patient registries to facilitate access to medical technologies.

Read more

17

Feb 2020

On the week of the 10th of February, MTRC published several posts related to the innovation funding schemes for medical devices in Europe, and the 2020 decisions for the innovation funding in Germany (NUB). Follow us on Instagram on @mtrc.market.access

Read more

10

Feb 2020

We have released the interview on the Market Access Insider channel on Youtube. The interview covered key stakeholders, procedure coding, functioning of the DRG system, reimbursement processes for medical technologies in Switzerland. Michel discussed the biggest mistakes made by the Med Tech companies on the market and advised on the best strategy on how to approach the market.

Read more

03

Feb 2020

On the week of the 27th of January, MTRC published several posts related to the NABM procedure codes for IVD tests in France, the frequency of update of procedural classifications in Europe, and the least active countries in relation to the Med Tech HTA in Europe. Follow us on Instagram on @mtrc.market.access

Read more

29

Jan 2020

We have released the interview on the Market Access Insider channel on Youtube. Prof. Banfi gave an extensive introduction to the history and the current state of the health technology assessment in Italy. Also, the current state of the HTA program in Lombardy was discussed.

Read more

27

Jan 2020

On the week of the 20th of January, MTRC published several posts related to the barriers for the adoption of EUnetHTA reports for health technologies, countries with a global budget payment system, the timing of government-sponsored coverage with evidence development programs PHRC and PRME in France, market access implications of the political changes in Russia, and the algorithm to classify different design of the studies. Follow us on Instagram on @mtrc.market.access

Read more

20

Jan 2020

On the week of the 13th of January, MTRC published several posts related to the upcoming change of the UK payment system, the top categories of medical devices evaluated by HTA organizations in Europe, the criteria for the creation of a new OPS procedure code in Germany, medical devices added to the High-Cost Device List in England in April 2020, the factors affecting the decision to introduce a new technology, and the least common topics of Med Tech HTA in Europe. Follow us on Instagram on @mtrc.market.access

Read more

20

Jan 2020

We have released the interview on the Market Access Insider channel on Youtube. The interview covered key stakeholders, reimbursement mechanism and pathways for procedures, implantable and invasive devices, coverage with evidence development program in Belgium. Michel shared a lot of first-hand insights from the reimbursement submissions in the country.

Read more

16

Jan 2020

In this post, we have summarized all the important developments with our services and products, which can be used by Med Tech, IVD and digital health companies to achieve better outcomes of the market access activities. This includes expansion of geographical coverage, growth in number of topics covered by the ready-made reimbursement reports, expertise in the e-health space, new services of health economics and value dossier, new free resources on market access, online educational materials on market access. Let us know, if you need any support with market access in European countries.

Read more

11

Jan 2020

On the week of 6th of January, MTRC published several posts related to the process of DRG change in England, list of technologies with different levels of added value (ASA) in France, countries offering access to hospital procedure volume information, improvements with glaucoma minimally invasive surgery reimbursement in England, the role of DRG in Scandinavia, and list of countries actively using DRG system for case-by-case reimbursement. Follow us on Instagram on mtrc.market.access

Read more

26

Dec 2019

We will share selective news, opinions, commentary, and analysis on the topic of European market access for medical technologies on Instagram. We are planning to develop specific content for Instagram, not fully matching the content of our websites. You can find our account at mtrc.market.access

Read more

09

Dec 2019

Since autumn 2019, MTRC started the release of the Market Access Magazine with an overview of key reimbursement news for the last quarter, along with analytical reviews on the topic of market access for medical technologies (reimbursement, funding, HTA, innovation payment schemes). Download free of charge from our website.

Read more

25

Nov 2019

Oleg Borisenko will attend the "MedTech Access Leaders Forum" in Berlin 3-5 of December 2019, as well as deliver five presentations with an overview of the reimbursement landscape for medical devices in EU5 during the third day of the meeting (5th of December). Stop by our booth to discuss your reimbursement needs.

Read more

25

Nov 2019

We have released the second part of the interview on the Market Access Insider channel on Youtube. Lluis Bohigas, Former General Director of Planning at the Spanish Ministry of Health, Spain.

Read more

11

Nov 2019

We have released the first part of the interview on the Market Access Insider channel on Youtube. Lluis Bohigas, Former General Director of Planning at the Spanish Ministry of Health, Spain.

Read more

28

Oct 2019

We have released the second part of the interview on the Market Access Insider channel on Youtube. Guillem Lopez Casasnovas, Professor of Economics at Universitat Pompeu Fabra, in Barcelona, Spain.

Read more

23

Oct 2019

This free, on-demand webinar provides an overview of key trends in market access for medical technologies in Europe, based on extensive consulting practice of MTRC: competition for hospital budget, disinvestment policies, developing therapies vs devices, innovation funding, value-based health care and others.

Read more

10

Oct 2019

MTRC continues releasing new seminars on the topics on market access. The seminar discusses key stakeholders, money flow, reimbursement in hospital and ambulatory settings, Nomenclature of medical services, specifics of reimbursement processes and the role of HTA.

Read more

10

Oct 2019

MTRC continues releasing new seminars on the topics on market access. The seminar discusses key stakeholders, money flow, reimbursement in hospital and ambulatory settings, role of DRG and fee for service model, specifics of reimbursement processes and the role of HTA.

Read more

01

Oct 2019

MTRC continues releasing new seminars on the topics on market access. This time the seminar covers a very complex market, Turkey. The seminar discusses key stakeholders, money flow, specifics of financing of public and university hospitals, reimbursement in hospital and ambulatory settings, innovation funding, details of the reimbursement application process and the role of health technology assessment.

Read more

24

Sep 2019

Responding to requests from our clients, we are starting to provide the services of development of value dossiers. We can support our clients with both early and core value dossiers. Dossiers can be developed from the global or European perspectives.

Read more

23

Sep 2019

In response to multiple requests from our clients, we have started the provision of service of health economic modeling for medical technologies and IVD tests in Europe. Both early and comprehensive models eligible for publication are supported.

Read more

21

Sep 2019

We have released the second part of the interview on the Market Access Insider channel on Youtube. The interview covered key stakeholders, procedure coding, principles of functioning of DRG system and add-on reimbursement for medical devices via LPPR List. Reimbursement pathways for devices, evidence requirements, pricing considerations, innovation funding (PHRC, PRME, forfeit innovation, Article 51, ETAPES program) were also discussed.

Read more

19

Sep 2019

Using its deep knowledge of market access pathways in Europe and a specific, fact-based, benchmarking approach, MTRC can support the development of reliable clinical and economic evidence generation strategy.

Read more

18

Sep 2019

Using its deep expertise in payment systems in Europe, MTRC has started provision of service of cost analysis to inform the development of health economic models and adaptation of existing models to settings of 19 European countries.

Read more

17

Sep 2019

MTRC is expanding its service offering to pharma companies. The scope of the services includes reimbursement analysis and strategy for hospital (high cost) drugs, cell and gene therapies, companion diagnostics, drug delivery systems and e-health solutions.

Read more

06

Sep 2019

The seminar includes overview of topics of reimbursement, funding, payment mechanisms for IVD tests in hospital, day case and out-patient settings, health technology assessment, innovation funding, role of clinical and economic evidence, stakeholder engagement. Data from 10 EU countries are used. The seminar is available as a pre-recorded on-demand webinar or full presentation in Acrobat PDF.

Read more

30

Aug 2019

Technical overviews include details of application processes for procedure codes and payments (e.g. DRG), inclusion into health benefit catalogs. Overviews are available as presentations in Acrobat PDF.

Read more

30

Aug 2019

Educational modules include an overview of key stakeholders, money flow, payment model for IVD tests in the ambulatory sector, the process of creation of reimbursement for novel IVD tests. Overviews are available for France, Germany, Italy, Switzerland. Overviews are available as presentations in Acrobat PDF.

Read more

30

Aug 2019

The overview includes key stakeholders, money flow, the structure of the NHS Scotland, payment model in the system, the role of the Scottish National Tariff, Specialised Clinical Services, commissioning of services outside Scotland (in England and EU), the role of health technology assessment.

Read more

19

Aug 2019

MTRC has released additional reimbursement overviews of hospital payment systems in European countries, including Greece, the Netherlands, Poland and Russia. In August-September 2019, the overviews for Belgium, Canada, Estonia, Turkey and USA are planned. Also, MTRC will shortly release the basic course on introduction into market access for IVD tests.

Read more

23

Jul 2019

This free webinar provides an overview of typical challenges of market access function (reimbursement, funding, evidence development) and how these challenges can be addressed using MTRC best practices. It is useful for those working in the market access capacity in the medical device industry.

Read more

01

Jul 2019

Seminars on hospital reimbursement system for the Netherlands and Russia were added to the online school, as well as the webinar for the Austrian system. MTRC online school is the most cost-effective way to learn about reimbursement systems in a structured way.

Read more

14

Jun 2019

A syndicated report (>80 pages) includes the overview and statistics of 16 key innovation funding and coverage with evidence development schemes in seven European countries: Austria, Belgium, England, France, Germany, the Netherlands and Switzerland. The price of the report is €1600.

Read more

10

Jun 2019

Director of MTRC will visit HTAi meeting in Cologne on the 19th of June 2019. Reach out to us at info@mtrconsult.com to schedule a meeting to discuss your reimbursement needs in Europe.

Read more

10

Jun 2019

Newly released interviews cover topics of organization and financing of health care systems in the Czech Republic, the Netherlands, Spain, the role of HTA in Italy and clinical decision-making for the introduction of novel technologies in the Netherlands.

Read more

10

Jun 2019

Descriptions are available as webinars or presentations in Acrobat PDF. They cover stakeholders, money flow, payment system, innovation funding, funding, and HTA landscape. Currently, overviews are available for 15 EU markets: Austria, Czech Republic, Denmark, England, Finland, France, Germany, Hungary, Italy, Norway, Romania, Spain, Sweden, and Switzerland. In June-July we will add overviews for Belgium, Greece, the Netherlands, Poland, Russia, and Turkey.

Read more

29

May 2019

The report includes all published reimbursement decisions for IVD tests in 2018 in European countries with established frameworks for out-patient reimbursement laboratory tests (Belgium, France, Germany, Netherlands, Switzerland).

Read more

28

May 2019

The report includes an overview of funding framework and all (as of May 2019) decisions from ultimate payers and decisions makers in England (NHS England, one CCG), Germany (G-BA), Netherlands (Zorginstituut Nederland), Norway (“New Methods” framework) and Switzerland (Federal Office of Public Health). More than 1000 decisions are included.

Read more

17

May 2019

The report summarizes HTA landscape, role of HTA in reimbursement processes in individual countries, provides list of HTAs per country, HTA body and program, per type of technology. In total, 12 countries, 51 organizations and more than 850 reports are included. Sample pages are available for download.

Read more

06

May 2019

We are happy to announce the launch of “Med Tech Market Access Academy” (www.a-marketaccess.com), a unique repository of online courses and seminars on European market access for medical devices and in-vitro diagnostic tests. Seminars are delivered as pre-recorded webinars and cover general introduction into market access, and country-specific overviews. We are launching the platform with 6 seminars (general introduction into market access, and reimbursement overviews in EU5) and expect to add 4-6 seminars each month.

Read more

06

May 2019

We are happy to announce the start of the first Youtube channel dedicated to market access for medical devices, in-vitro diagnostic tests, and e-health solutions, “Market Access Insider”. In the first season of the program, we will weekly release videos of interviews with decision-makers, researchers, consultants, physicians and patient representatives on the topics of the payment system, health insurance, reimbursement pathways, health technology assessment and others in European countries. The first season will include interviews with experts from the Czech Republic, France, Germany, Italy, the Netherlands, and Spain.

Read more

16

Nov 2018

MTRC is offering an opportunity to access 2019 market access retainer scheme using the discounted price during November-December 2018. The benefit to our clients of entering into this scheme is the forward planning of market access-related project activities and more effective budget management.

Read more

08

Oct 2018

MTRC expands the coverage of EU countries with its core service of reimbursement analysis (procedure coding, payment model, reimbursement tariffs). Work is done by MTRC personnel, supported by local reimbursement experts. Contact us, if you want to learn more.

Read more

04

Oct 2018

The article "Congenital heart defect repair with ADAPT tissue engineered pericardium scaffold: An early-stage health economic model", published in Plos One presented the cost effectiveness of tissue engineered bovine tissue pericardium scaffold (CardioCel) for the repair of congenital heart defects in comparison with surgery using xenogeneic, autologous, and synthetic patches over a 40-year time horizon from the perspective of the UK National Health Service.

Read more

09

Sep 2018

MTRC performs the analysis using administrative databases. Reporting of procedure volume is done according to the established procedural classifications (e.g., OPCS in England, OPS in Germany). Data are available for Austria, Belgium, England, France, Germany, the Netherlands, Sweden, and Switzerland. In other countries, it might be possible to obtain data from patient registries or clinical societies.

Read more

10

Aug 2018

An article “An early analysis of cost-utility of baroreflex activation therapy in advanced chronic heart failure in Germany” was published in the BMC Cardiovascular Disorders. The study concluded that Baroreflex activation therapy (BAT) using the Barostim neo™ device (CVRx Inc., Minneapolis, MN, USA) compared with optimized medical management in patients with advanced chronic heart failure (NYHA class III) who were not eligible for treatment with cardiac resynchronization therapy, can be cost-effective from a statutory health insurance perspective in Germany over a lifetime horizon. The ICER was €27,951/QALY (95% CI €21,357–82,970).

Read more

25

Jun 2018

MTRC has developed reimbursement overviews for 14 EU countries. Overviews cover stakeholders, money flow, payment model, DRG system, innovation funding, coverage with evidence development, the role of health technology assessment, funding frameworks and reimbursement pathways. Reports are delivered in PowerPoint. Video explanations are available as well.

Read more

04

Jun 2018

Report includes analysis for the following procedures: radiofrequency ablation, endoscopic plication and suturing, injection of bulking agents and endoscopic augmentation of the lower esophageal sphincter using hydrogel implants. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland.

Read more

04

Jun 2018

Report includes analysis for the following procedures: surgical clipping, endovascular placement of a flow diversion device, endovascular coiling and stent-assisted coiling. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland.

Read more

01

Jun 2018

European Med Tech and IVD Reimbursement Consulting Ltd. released a report, which identifies and provides an overview of the innovative payment schemes for medical devices and in-vitro diagnostic tests in European countries. The report was supported by the grant from the Med Tech Europe. Access the full version of the report at our web-site.

Read more

25

Apr 2018

In April 2018, Oleg Borisenko with support from the MTRC launched an international stipend and mentoring program. The objective of the program is to support medical students in developing countries with achieving maximum results in a medical profession. For the first round of the program (six months until Oct 2018), three students were selected. The program includes a stipend, bi-weekly meetings on different subjects (goal setting, evidence-based medicine, clinical epidemiology, medical experiment, marketing, publication standards and others) and a personal mentoring of Oleg Borisenko.

Read more

19

Apr 2018

The CEO of MTRC co-authored the article "Cost–utility analysis of bariatric surgery", published in the leading European surgical journal, British Journal of Surgery. Analysis indicated that currently used surgical methods in England were found to be cost saving over the lifetime of individuals treated in England.

Read more

17

Jan 2018

Article “Cost-effectiveness analysis of bariatric surgery for morbid obesity in Belgium” published in the “Journal of Medical Economics” provides insights about economic outcomes of bariatric surgery in Belgium using Markov modeling. Over the 10-year horizon, bariatric surgery led to a cost increment of €3,788 and 1.4 additional QALY (€2,809/QALY) compared with optimal medical management. Over lifetime horizon, surgery led to 1.1 life years and 5.0 QALY gains and €9,332/patient average cost savings.

Read more

04

Dec 2017

CEO of the MTRC, Dr. Oleg Borisenko will attend the "MedTech Access Leaders Forum" 5-7 of December in Berlin. Please, write to info@mtrconsult.com if you would be interested to arrange a meeting to discuss your market access needs in Europe. 

Read more

23

Nov 2017

We have developed a one-day training in market access for IVD companies, covering essential areas of reimbursement, funding, health technology assessment, the role of clinical and economic evidence, stakeholder engagement. The seminar is based on the in-house expertise and extensive interview program with laboratory experts. During the course, both general aspects of market access and specific pathways for IVD tests in 12 European countries are reviewed. CEO Oleg Borisenko performs seminar on the client’s facility.

Read more

07

Nov 2017

The article "Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study" published in the Journal of Hepatology provides valuable insights into efficacy, safety and cost outcomes of the innovative method for managing refractory ascites.

Read more

31

Oct 2017

The article "Patient Characteristics, Procedural and Safety Outcomes of Bariatric Surgery in England: a Retrospective Cohort Study—2006–2012" published in Obesity Surgery reviews the UK experience with bariatric surgery.

Read more

20

Sep 2017

CEO of the MTRC, Dr. Oleg Borisenko will be present at the 2nd Annual Medical Devices Sales and Marketing Conference, 28-29 of September in Cologne, Germany. Please, contact us at info@mtrconsult.com if you would like to arrange a meeting to discuss your needs with reimbursement and market access in Europe.

Read more

05

Jun 2017

MTRC has developed a comprehensive introductory course in European market access. Course has duration between few hours and one day and takes place on your site. Topics include payment mechanisms, reimbursement pathways, role of HTA, economic argumentation and others. The cost is 5,000 euros irrespective of number of participants and duration of the course.

Read more